Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal growth and up regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. GLP2 prevents intestinal hypoplasia resulting from total parenteral nutrition.
The Glucagon-like peptide 2 receptor pipeline market research report provides comprehensive information on the therapeutics under development for Glucagon-like peptide 2 receptor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Glucagon-like peptide 2 receptor and features dormant and discontinued projects.
Glucagon-like Peptide 2 Receptor Pipeline Products Market Segmentation by Therapy Areas
The key therapy areas in the Glucagon-like peptide 2 receptor pipeline products market are gastrointestinal, immunology, metabolic disorders, musculoskeletal disorders, and other diseases.
Glucagon-like Peptide 2 Receptor Pipeline Products Market Analysis by Therapy Areas
For more therapy area insights into the Glucagon-like peptide 2 receptor pipeline products market, download a free report sample
Glucagon-like Peptide 2 Receptor Pipeline Products Market Segmentation by Routes of Administration
The key routes of administration in the Glucagon-like peptide 2 receptor pipeline products market are subcutaneous, parenteral, oral, and intravenous.
Glucagon-like Peptide 2 Receptor Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights into the Glucagon-like peptide 2 receptor pipeline products market, download a free report sample
Glucagon-like Peptide 2 Receptor Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Glucagon-like peptide 2 receptor pipeline products market are peptide, fusion protein, synthetic peptide, recombinant peptide, recombinant protein, and small molecule.
Glucagon-like Peptide 2 Receptor Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the Glucagon-like peptide 2 receptor pipeline products market, download a free report sample
Competitive Landscape
Some of the leading companies in the Glucagon-like peptide 2 receptor pipeline products market are 9 Meters Biopharma Inc, Amogen Pharma Pvt Ltd, Applied Molecular Transport Inc, Bainan Biotech ApS, Entera Bio Ltd, Hanmi Pharmaceuticals Co Ltd, and Huons Global Co Ltd.
Glucagon-like Peptide 2 Receptor Pipeline Products Market Analysis by Companies
To know more about the leading companies in the Glucagon-like peptide 2 receptor pipeline products market, download a free report sample
Glucagon-like Peptide 2 Receptor Pipeline Products Market Report Overview
Key Therapy Areas | Gastrointestinal, Immunology, Metabolic Disorders, Musculoskeletal Disorders, Other Diseases |
Key Mechanisms of Action | Glucagon Like Peptide 2 Receptor Agonist |
Key Routes of Administration | Subcutaneous, Parenteral, Oral, And Intravenous |
Key Molecule Type | Peptide, Fusion Protein, Synthetic Peptide, Recombinant Peptide, Recombinant Protein, Small Molecule |
Leading Companies | 9 Meters Biopharma Inc, Amogen Pharma Pvt Ltd, Applied Molecular Transport Inc, Bainan Biotech Aps, Entera Bio Ltd, Hanmi Pharmaceuticals Co Ltd, And Huons Global Co Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Glucagon-like peptide 2 receptor (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Glucagon-like peptide 2 receptor (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Glucagon-like peptide 2 receptor (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Glucagon-like peptide 2 receptor (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Glucagon-like peptide 2 receptor (Ophthalmology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Glucagon-like peptide 2 receptor (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Glucagon-like peptide 2 receptor (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Amogen Pharma Pvt Ltd
Applied Molecular Transport Inc
Bainan Biotech ApS
Entera Bio Ltd
Hanmi Pharmaceuticals Co Ltd
Huons Global Co Ltd
OPKO Health Inc
Peg-Bio BioPharma Co Ltd
PhaseBio Pharmaceuticals Inc
Sosei Group Corp
Takeda Pharmaceutical Co Ltd
Tasly Pharmaceutical Group Co Ltd
VectivBio Holding AG
Zealand Pharma AS
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the Glucagon-like peptide 2 receptor products market?
The key therapy areas in the Glucagon-like peptide 2 receptor pipeline products market are gastrointestinal, immunology, metabolic disorders, musculoskeletal disorders, other diseases.
-
What are the key mechanisms of action in the Glucagon-like peptide 2 receptor pipeline products market?
The key mechanisms of action in the Glucagon-like peptide 2 receptor pipeline products market are Glucagon Like Peptide 2 Receptor Agonist.
-
What are the key routes of administration in the Glucagon-like peptide 2 receptor pipeline products market?
The key routes of administration in the Glucagon-like peptide 2 receptor pipeline products market are subcutaneous, parenteral, oral, and intravenous.
-
What are the key molecule types in the Glucagon-like peptide 2 receptor pipeline products market?
The key molecule types in the Glucagon-like peptide 2 receptor pipeline products market are peptide, fusion protein, synthetic peptide, recombinant peptide, recombinant protein, small molecule.
-
Which are the leading companies in the Glucagon-like peptide 2 receptor pipeline products market?
Some of the leading companies in the Glucagon-like peptide 2 receptor pipeline products market are 9 Meters Biopharma Inc, Amogen Pharma Pvt Ltd, Applied Molecular Transport Inc, Bainan Biotech ApS, Entera Bio Ltd, Hanmi Pharmaceuticals Co Ltd, and Huons Global Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.